Disentangling the role of gray matter volume and concentration in autism spectrum disorder: A meta-analytic investigation of 25 years of voxel-based morphometry research
- PMID: 38960075
- DOI: 10.1016/j.neubiorev.2024.105791
Disentangling the role of gray matter volume and concentration in autism spectrum disorder: A meta-analytic investigation of 25 years of voxel-based morphometry research
Abstract
Despite over two decades of neuroimaging research, a unanimous definition of the pattern of structural variation associated with autism spectrum disorder (ASD) has yet to be found. One potential impeding issue could be the sometimes ambiguous use of measurements of variations in gray matter volume (GMV) or gray matter concentration (GMC). In fact, while both can be calculated using voxel-based morphometry analysis, these may reflect different underlying pathological mechanisms. We conducted a coordinate-based meta-analysis, keeping apart GMV and GMC studies of subjects with ASD. Results showed distinct and non-overlapping patterns for the two measures. GMV decreases were evident in the cerebellum, while GMC decreases were mainly found in the temporal and frontal regions. GMV increases were found in the parietal, temporal, and frontal brain regions, while GMC increases were observed in the anterior cingulate cortex and middle frontal gyrus. Age-stratified analyses suggested that such variations are dynamic across the ASD lifespan. The present findings emphasize the importance of considering GMV and GMC as distinct yet synergistic indices in autism research.
Keywords: Cerebellum; Default mode network; FMRI; Heterogeneity; Magnetic resonance imaging; NeuroSynth; Signed differential mapping; Voxel-based morphometry.
Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors report no declarations of interest.
Similar articles
-
Systematic review and meta-analysis: multimodal functional and anatomical neural alterations in autism spectrum disorder.Mol Autism. 2024 Apr 4;15(1):16. doi: 10.1186/s13229-024-00593-6. Mol Autism. 2024. PMID: 38576034 Free PMC article.
-
Gray matter abnormalities in pediatric autism spectrum disorder: a meta-analysis with signed differential mapping.Eur Child Adolesc Psychiatry. 2017 Aug;26(8):933-945. doi: 10.1007/s00787-017-0964-4. Epub 2017 Feb 23. Eur Child Adolesc Psychiatry. 2017. PMID: 28233073
-
Brain gray matter alterations and associated demographic profiles in adults with autism spectrum disorder: A meta-analysis of voxel-based morphometry studies.Aust N Z J Psychiatry. 2016 Aug;50(8):741-53. doi: 10.1177/0004867415623858. Epub 2016 Jan 14. Aust N Z J Psychiatry. 2016. PMID: 26769980 Review.
-
Functional Alterations Associated with Structural Abnormalities in Adults with High-Functioning Autism Spectrum Disorder.Brain Connect. 2020 Sep;10(7):368-376. doi: 10.1089/brain.2020.0746. Epub 2020 Jul 23. Brain Connect. 2020. PMID: 32517487
-
Structural Gray Matter Differences During Childhood Development in Autism Spectrum Disorder: A Multimetric Approach.Pediatr Neurol. 2015 Oct;53(4):350-9. doi: 10.1016/j.pediatrneurol.2015.06.013. Epub 2015 Jun 25. Pediatr Neurol. 2015. PMID: 26231265
Cited by
-
From Serendipity to Precision: Integrating AI, Multi-Omics, and Human-Specific Models for Personalized Neuropsychiatric Care.Biomedicines. 2025 Jan 12;13(1):167. doi: 10.3390/biomedicines13010167. Biomedicines. 2025. PMID: 39857751 Free PMC article. Review.
-
Common and distinct patterns of brain activity alterations during inhibitory control in depression and psychostimulant users: a comparative meta-analysis of task-based fMRI studies.Psychol Med. 2025 Jul 28;55:e218. doi: 10.1017/S0033291725101141. Psychol Med. 2025. PMID: 40717270 Free PMC article.
-
Curcumin: A Golden Approach to Healthy Aging: A Systematic Review of the Evidence.Nutrients. 2024 Aug 15;16(16):2721. doi: 10.3390/nu16162721. Nutrients. 2024. PMID: 39203857 Free PMC article.
-
Quinoline Quest: Kynurenic Acid Strategies for Next-Generation Therapeutics via Rational Drug Design.Pharmaceuticals (Basel). 2025 Apr 22;18(5):607. doi: 10.3390/ph18050607. Pharmaceuticals (Basel). 2025. PMID: 40430428 Free PMC article. Review.
-
Navigating Neurodegeneration: Integrating Biomarkers, Neuroinflammation, and Imaging in Parkinson's, Alzheimer's, and Motor Neuron Disorders.Biomedicines. 2025 Apr 25;13(5):1045. doi: 10.3390/biomedicines13051045. Biomedicines. 2025. PMID: 40426872 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical